Viewing Study NCT06833268


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2025-12-25 @ 3:11 PM
Study NCT ID: NCT06833268
Status: COMPLETED
Last Update Posted: 2025-07-08
First Post: 2025-02-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan
Sponsor: Daiichi Sankyo
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module